Literature DB >> 853128

Interaction of factor VIII antigen in hemophilic plasmas with human antibodies to factor VIII.

T S Zimmerman, L de la Pointe, T S Edgington.   

Abstract

By utilizing a simple modification of previous immunological assays, we have demonstrated that most, if not all, hemophilic plasmas contain antigen reactive with human antibodies directed against Factor VIII procoagulant activity (VIIIc). Antibodies developing in a nonhemophiliac patient and in a hemophiliac patient gave similar results. The VIIIc antigen so identified was removed from hemophilic plasmas with immobilized rabbit antibody which reacted with normal VIIIc and von Willebrand's disease antigen. These data suggest that there are greater antigenic similarities between normal and hemophilic Factor VIII than previously thought.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 853128      PMCID: PMC372307          DOI: 10.1172/JCI108721

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.

Authors:  H J Weiss; I W Hoyer
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

2.  The absorption of human factor VIII neutralizing antibody by factor VIII.

Authors:  R Biggs
Journal:  Br J Haematol       Date:  1974-02       Impact factor: 6.998

3.  Immunologic studies in haemophilia A.

Authors:  L Holmberg; I M Nilsson
Journal:  Scand J Haematol       Date:  1973

4.  Factor VIII and IX variants. Relationship between haemophilia B M and haemophilia B+.

Authors:  D Meyer; M J Larrieu; B Obert
Journal:  Eur J Clin Invest       Date:  1971-09       Impact factor: 4.686

5.  Two types of haemophilia (A+ and A-): a study of 48 cases.

Authors:  K W Denson; R Biggs; M E Haddon; R Borrett; K Cobb
Journal:  Br J Haematol       Date:  1969-08       Impact factor: 6.998

6.  Studies of cross-reactivity of acquired factor VIII inhibitor activity in hemophilic plasma.

Authors:  C F Abildgaard; J Vanderheiden; A Lindley; F Rickles
Journal:  Thromb Diath Haemorrh       Date:  1967-12-31

7.  Inactive factor VIII in hemophilia A and Willebrand's disease. A study of 117 cases.

Authors:  K Lechner
Journal:  Acta Haematol       Date:  1972       Impact factor: 2.195

8.  Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.

Authors:  D P Stites; E J Hershgold; J D Perlman; H H Fudenberg
Journal:  Science       Date:  1971-01-15       Impact factor: 47.728

9.  Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.

Authors:  B Bennett; O D Ratnoff
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

10.  Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities.

Authors:  T S Zimmerman; T S Edgington
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  3 in total

1.  Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.

Authors:  M J Weinstein; L E Chute
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

2.  Immunoradiometric measurement of the factor VIII procoagulant antigen.

Authors:  J Lazarchick; L W Hoyer
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

3.  Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.

Authors:  M D Kazatchkine; Y Sultan; E J Burton-Kee; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.